IKNA NASDAQ
Ikena Oncology, Inc.
1W: +12.6%
1M: +6.7%
3M: +18.2%
1Y: -14.9%
3Y: -74.0%
$17.16
Last traded 2025-07-25 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$48M
+11.2% ▲
Net Income
-$52M
-6.4% ▼
EPS (Diluted)
$0.00
+100.0% ▲
EBITDA
-$48M
+0.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $31M | $16M | $9M | $0 | $0 |
| YoY Growth | +237.0% | -49.6% | -41.3% | -100.0% | +0.0% |
| Cost of Revenue | $47M | $64M | $1M | $490K | $0 |
| Gross Profit | -$16M | $14M | $8M | -$490K | $0 |
| Gross Margin | -52.0% | 87.0% | 88.9% | — | — |
| R&D Expenses | $47M | $64M | $60M | $30M | $29M |
| SG&A Expenses | $18M | $22M | $25M | $24M | $21M |
| Operating Expenses | $18M | $84M | $84M | $54M | $49M |
| Operating Income | -$34M | -$71M | -$75M | -$59M | -$48M |
| Operating Margin | -110.2% | -454.0% | -823.3% | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$34M | -$69M | -$68M | -$49M | -$46M |
| Tax Expense | $0 | $0 | -$162K | $152K | $350K |
| Net Income | -$34M | -$69M | -$68M | -$49M | -$52M |
| Net Margin | -110.1% | -440.3% | -744.2% | — | — |
| EPS (Diluted) | $-0.95 | $-1.90 | $-1.63 | $-1.02 | $0.00 |
| EBITDA | -$34M | -$70M | -$74M | -$49M | -$48M |
| Shares Outstanding | 36M | 36M | 42M | 48M | 0 |